The contents of the labeling, promotion, and advertisement of cosmetics shall not be deceptive or exaggerated.
Cosmetics shall not be so labeled, promoted, or advertised as having medical efficacy.
A mass media enterprise being commissioned to publish or broadcast a cosmetics advertisement shall maintain the particulars of its principal, including name, national identification card number or establishment registration document number of company, business, corporation or group, domicile or address, telephone number, etc., for six months from the date of such advertisement, and shall not evade, obstruct, or refuse when requested by the competent authority for such particulars.
Regulations for the determination criteria of deceptive or exaggerated contents referred to in Paragraph 1, medical efficacy referred to in Paragraph 2, promotion or advertisement contents and methods, and other matters to be observed shall be prescribed by the central competent authority.

Cosmetics businesses shall establish and maintain data on direct supply sources and destinations of products. However, this provision shall not apply to data on products directly sold to consumers.
Regulations governing the scope, items, contents, methods for establishment and maintenance, retention period of data, and other matters to be observed with regard to the preceding paragraph shall be prescribed by the central competent authority.

Cosmetics businesses shall report the serious adverse effects generated by cosmetics under conditions of normal or reasonable use, or the findings when product could possibly pose a hazard to hygiene and safety or a risk of harm, and handle them in accordance with the provisions of Article 10 of the Consumer Protection Act.
Serious adverse effects mentioned in the preceding paragraph shall refer to one of the following conditions:
1.Death;
2.Life-threatening;
3.Temporary or permanent disability/incapacity;
4.Congenital anomaly/birth defect of fetus/infant;
5.Resulting in hospitalization of users for treatment.
Regulations on reporting population, methods, contents, deadlines, and other matters to be observed with regard to Paragraph 1 shall be prescribed by the central competent authority.